Key result
Pentamethylquercetin increases adiponectin expression in adipocytes via PPARγ, TNF-α, and IL-6 pathways.
Why the study?
Up-regulation of adiponectin expression benefits metabolic disorders, but the effect of pentamethylquercetin on adiponectin production in adipocytes was unknown.
Does pentamethylquercetin improve adiponectin expression in differentiated 3T3-L1 cells?
Does pentamethylquercetin improve adiponectin expression in differentiated 3T3-L1 cells?
Pentamethylquercetin up-regulates adiponectin expression in 3T3-L1 adipocytes via a PPARγ-dependent mechanism and reduces inflammatory cytokines, suggesting potential for treating metabolic diseases.
May support PMQ as adiponectin modulator in preclinical models; leaves open translation to human metabolic outcomes.
Adiponectin is an adipocyte-derived hormone that plays a pivotal role in the regulation of lipid and glucose metabolism. Up-regulation of adiponectin expression and production has been shown to benefit for metabolic disorders, including type 2 diabetes, hyperlipidemia, etc. The present study investigated whether the novel polymethoxylated flavonoid pentamethylquercetin (PMQ), a member of polymethoxylated flavonoids family which is present in seabuckthorn (Hippophae L.) would affect adiponectin production in differentiated 3T3-L1 adipocytes. It was found that PMQ increased the adiponectin mRNA and protein expressions in adipocytes in time- and concentration-dependent manners. The PPARγ pathway plays a important roles in this effect of PMQ because blockade of PPARγ by GW9662 eliminates the PMQ-induced up-regulation of adiponectin expression. Furthermore, significant decreases of mRNA expression and secretion of TNF-α and IL-6 were also observed in PMQ-treated cells. Taken together, our study demonstrated that PMQ up-regulates adiponectin expression via a mechanism that implicates PPARγ together with TNF-α and IL-6, suggesting that PMQ might be a potential candidate for the treatment of metabolic diseases.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2011) studied this question. Pentamethylquercetin (PMQ) was evaluated on Adiponectin mRNA and protein expressions. Pentamethylquercetin increased adiponectin mRNA and protein expressions in differentiated 3T3-L1 adipocytes via a mechanism involving PPARγ, TNF-α, and IL-6.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: